Change in the Board of Directors at DanCann Pharma A/S
COPENHAGEN, Denmark, 19 March 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby announce that Magnus Østergaard Dahlmann has chosen to transfer the position of Chairman of the Board of Directors of the biopharmaceutical company DanCann Pharma A/S to Carsten Trads due to health reasons. Magnus Østergaard Dahlmann will continue as a member of the company’s Board of Directors.The change of chairmanship is quite undramatic and is due to a desire from Magnus Østergaard Dahlmann to disengage resources in connection with a long-term course of treatment, and